Alkermes
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.About ALKS
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL.
ALKS Key Statistics
Stock Snapshot
Alkermes(ALKS) stock is priced at $38.58, giving the company a market capitalization of 6.43B. It carries a P/E multiple of 42.57.
As of 2026-05-14, Alkermes(ALKS) stock has fluctuated between $38.21 and $39.12. The current price stands at $38.58, placing the stock +1.0% above today's low and -1.4% off the high.
Alkermes(ALKS) shares are trading with a volume of 116.72K, against a daily average of 2.56M.
During the past year, Alkermes(ALKS) stock moved between $25.17 at its lowest and $39.56 at its peak.
During the past year, Alkermes(ALKS) stock moved between $25.17 at its lowest and $39.56 at its peak.
ALKS News
On May 12, 2026, Alkermes announced positive topline Phase 3 REVITALYZ results showing that once‑nightly LUMRYZ improved excessive daytime sleepiness and other...
Baird analyst Luke Herrmann raised the firm’s price target on Alkermes (ALKS) to $48 from $45 and keeps an Outperform rating on the shares. The firm updated its...
The stock’s movement comes as the Healthcare sector is currently the best-performing sector, gaining 2.43%, while the broader market is mixed, with the S&P 500...
Analyst ratings
81%
of 16 ratingsMore ALKS News
Soft earnings didn't appear to concern Alkermes plc's ( ) shareholders over the last week. We did some digging, and we believe the earnings are stronger than th...
Alkermes (ALKS) announced positive topline results from the REVITALYZ double-blind, placebo-controlled, randomized withdrawal, multicenter phase 3 study evaluat...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Advertisement Context for Alkermes stock Alkermes (ALKS) has been on investors’ radar after recent share price moves, with the stock showing gains over the pa...
If you are wondering whether Alkermes at around US$35.40 still offers value, it helps to step back and look at what the recent share performance might be implyi...
Alkermes plc (ALKS) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisio...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.